from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3064c/-

LFCtreatmentdescriptionclass of inhibitor

-0.543

Amikacinug/mL Amikacintranslation

-0.401

Cap5-10ug/mL Capreomycintranslation

-0.373

Rox10-50 ug/mL Roxithromycintranslation

-0.300

SM2-5 ug/mL Streptomycintranslation

-0.575

Tet5-10 ug/mL Tetracyclinetranslation

-0.328

Rif0.2-5ug/mL Rifampicintranscription

-0.611

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.769

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.753

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

2.028

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.367

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.956

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.271

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.862

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.357

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.213

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.112

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

2.271

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.046

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

2.168

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.118

KCN5-20 ug/mL Potassium cyaniderespiration

0.026

NaN30.2-2 mM Sodium aziderespiration

0.995

Nigericin50 uM Nigericinrespiration

0.298

TRC10-150 ug/mL Triclosanrespiration

1.212

TRZ10-25 ug/mL Thioridazinerespiration

1.259

Valinomycin0.5-10 uM Valinomycinrespiration

0.034

ZnSO42 mM ZnSO4respiration

2.778

menadione6-10 ug/mL Menadionerespiration

-0.176

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.534

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.412

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.141

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.757

NRP_1Non-replicating persistence stage 1dosRassociated

-0.341

Amp0.2mg/mL AmpicillincellWall

-0.199

Cephalexin20-100 ug/mL CephalexincellWall

-0.485

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.397

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.420

EMB10-20 ug/mL EthambutolcellWall

-0.312

Eta12-40 ug/mL EthionamidecellWall

-0.200

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.529

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.654

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.448

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.448

BZA0.12 mg/mL BenzamidearomaticAmides

-0.608

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.250

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.087

H2O24 mM hydrogen peroxideDNAdamaging

-0.238

Levo10 ug/mL LevofloxacinDNAdamaging

-0.561

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.236

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.442

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.556

UVUV-irradiationDNAdamaging

2.503

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.749

Antimycin12.5-50 ug/mL Antimycin A?

0.050

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.799

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.867

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.127

PA8240.2-2 ug/mL PA-824?

0.426

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.339

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.121

Verapamil50 uM Verapamil?

0.037

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.131

methoxatin10-20 ug/mL Methoxatin?